Clinical Trials Directory

Trials / Completed

CompletedNCT01941810

Bovine Lactoferrin Supplement in Improving Taste in Patients With Cancer Receiving Chemotherapy

A Pilot Study of Bovine Lactoferrin in Cancer Patients Reporting Taste Disturbances While Receiving Chemotherapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot phase II trial studies how well bovine lactoferrin supplement works in improving taste in patients with cancer receiving chemotherapy. Bovine lactoferrin supplement may help improve the ability to taste food in patients who are receiving chemotherapy.

Detailed description

PRIMARY OBJECTIVES: I. To assess the impact of lactoferrin supplementation (bovine lactoferrin supplement) on self-reported taste and smell disturbances in cancer patients receiving chemotherapy. SECONDARY OBJECTIVES: I. To assess the impact of lactoferrin supplementation on the baseline lipid peroxidation byproducts in saliva in cancer patients as measured by the thiobarbituric acid reactive substances (TBARs) assay. II. To assess the impact of lactoferrin supplementation on the ability of cancer patients to generate increased lipid peroxidation byproducts when challenged with a weak iron-containing solution. III. To assess the impact of lactoferrin supplementation on self-reported general quality of life and on specific self-reported anorexia/cachexia issues in cancer patients with established chemotherapy-induced taste disturbances. IV. To assess the incidence of vitamin D deficiency in cancer patients with chemotherapy induced taste changes. OUTLINE: Patients receive bovine lactoferrin supplement orally (PO) three times daily (TID) for 1 month. After completion of study treatment, patients are followed up at 2 weeks and 1 month.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTbovine lactoferrin supplementGiven PO
OTHERquestionnaire administrationAncillary studies
PROCEDUREquality-of-life assessmentAncillary studies
OTHERlaboratory biomarker analysisCorrelative studies

Timeline

Start date
2014-02-01
Primary completion
2015-10-01
Completion
2015-10-01
First posted
2013-09-13
Last updated
2018-07-03

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01941810. Inclusion in this directory is not an endorsement.